Oncology

Pioneering leading edge cancer care, research and innovation

550 cancer usnwr

The Indiana University Health Medical Center and its renowned oncology experts are leading the way to advance patient care through comprehensive clinical trials and novel therapies.

Since 2012, Indiana University Health Medical Center has had the honor of being ranked #1 in Indiana by U.S. News and World Report.

Accredited as high performing in 13 adult procedures and conditions, IU Health Medical Center stands as Indiana’s most comprehensive healthcare system, dedicated to delivering cutting-edge medicine and treatments.

IU Health has the state's only academic medical center and a unique partnership with Indiana University School of Medicine—one of the nation’s leading medical schools—providing patients access to groundbreaking research and innovative treatments that complement high-quality patient care. Awarded $214.8 million in total funding from the National Institute of Health in 2022, it secured its rank as the #14 NIH-funded public school.

At IU Health Medical Center, our nationally recognized oncologists have unmatched expertise to treat a variety of cancers such as leukemia, lymphoma, melanoma, breast, kidney, colon, prostate, pancreatic, head and neck, orthopedic, uterine and ovarian cancers. From exploring molecular changes to developing targeted therapies to address global health disparities, our collaborative research leads to protocol-defining discoveries that influence treatments and save lives.

  • Pioneered and continually refining the medical approach to treatment of patients with metastatic testicular cancer through the use of platinum combination chemotherapy, increasing the survival rate from 10% to now 95% cure rate. There are over 300,000 survivors worldwide today.
  • Pioneered the surgical technique of retroperitoneal lymph node dissection (RPLND) for patients with metastatic testicular cancer and one of the world’s largest referral centers for the RPLND procedure
  • Developed HIFU as a non-invasive therapy for prostate cancer
  • Developed preventative screening techniques and diagnostic procedures used nationwide to accurately diagnose and treat pancreatic and colorectal cancer
  • Largest and most experienced percutaneous nephrolithotomy program
  • Pioneered the development of Indiana Pouch, now performed on over 1,000 patients
  • Core Institute of the Blood and Marrow Transplant Clinical Trials Network and accredited by the Foundation for the Accreditation of Cellular Therapy
  • Indiana University Melvin and Bren Simon Cancer Center is a National Cancer Institute designatd cancer center, 1 of only 54 in the nation
  • 1 of only 33 members of the National Comprehensive Cancer Network
  • The Komen Tissue Bank, established at the IU Simon Cancer Center, is the only repository in the world for normal breast tissue, matched serum, plasma and DNA.
  • Leading the development of personalized therapies specifically treating triple-negative breast cancer patients
  • Global partnerships with the Abu Dhabi Stem Cell Center and AMPATH in Kenya to advance innovative care world-wide
USNWR Badge

Highest Level of Care

Accredited as high performing in 13 adult procedures and conditions, IU Health Medical Center stands as Indiana’s most comprehensive healthcare system, dedicated to delivering cutting-edge medicine and treatments.

IU Health has the state's only academic medical center and a unique partnership with Indiana University School of Medicine—one of the nation’s leading medical schools—providing patients access to groundbreaking research and innovative treatments that complement high-quality patient care. Awarded $214.8 million in total funding from the National Institute of Health in 2022, it secured its rank as the #14 NIH-funded public school.

At IU Health Medical Center, our nationally recognized oncologists have unmatched expertise to treat a variety of cancers such as leukemia, lymphoma, melanoma, breast, kidney, colon, prostate, pancreatic, head and neck, orthopedic, uterine and ovarian cancers. From exploring molecular changes to developing targeted therapies to address global health disparities, our collaborative research leads to protocol-defining discoveries that influence treatments and save lives.

  • Pioneered and continually refining the medical approach to treatment of patients with metastatic testicular cancer through the use of platinum combination chemotherapy, increasing the survival rate from 10% to now 95% cure rate. There are over 300,000 survivors worldwide today.
  • Pioneered the surgical technique of retroperitoneal lymph node dissection (RPLND) for patients with metastatic testicular cancer and one of the world’s largest referral centers for the RPLND procedure
  • Developed HIFU as a non-invasive therapy for prostate cancer
  • Developed preventative screening techniques and diagnostic procedures used nationwide to accurately diagnose and treat pancreatic and colorectal cancer
  • Largest and most experienced percutaneous nephrolithotomy program
  • Pioneered the development of Indiana Pouch, now performed on over 1,000 patients
  • Core Institute of the Blood and Marrow Transplant Clinical Trials Network and accredited by the Foundation for the Accreditation of Cellular Therapy
  • Indiana University Melvin and Bren Simon Cancer Center is a National Cancer Institute designatd cancer center, 1 of only 54 in the nation
  • 1 of only 33 members of the National Comprehensive Cancer Network
  • The Komen Tissue Bank, established at the IU Simon Cancer Center, is the only repository in the world for normal breast tissue, matched serum, plasma and DNA.
  • Leading the development of personalized therapies specifically treating triple-negative breast cancer patients
  • Global partnerships with the Abu Dhabi Stem Cell Center and AMPATH in Kenya to advance innovative care world-wide
USNWR Badge

Grants Received

High-Tech Shared Research Support Facilities

Actively Recruiting Clinical Trials

IU Health Medical Center’s research provides deep expertise across every cancer discipline. Areas of clinical research cover disparities in cancer treatment and survivorship, liver disease, blood and bone marrow cells, lung, kidney, prostate, breast and bladder cancer, retroperitoneal lymph node dissection, melanoma, leukemia, tissue procurement, cell transplants and more. View an active clinical trial list.

Clinical Research

IU Health Medical Center’s research provides deep expertise across every cancer discipline. Areas of clinical research cover disparities in cancer treatment and survivorship, liver disease, blood and bone marrow cells, lung, kidney, prostate, breast and bladder cancer, retroperitoneal lymph node dissection, melanoma, leukemia, tissue procurement, cell transplants and more. View an active clinical trial list.

Our Physician Leaders

IU Health Medical Center is home to world renowned physician experts and care teams who work in collaboration with the IU School of Medicine, the largest medical school in the country.

Kelvin P. Lee, MD

Hematology - Oncology

View Doximity Profile

Bryan P. Schneider, MD

Hematology - Oncology

View Doximity Profile

Lawrence H. Einhorn, MD

Hematology - Oncology

View Doximity Profile

Rafat Abonour, MD

Bone Marrow Transplant, Hematology - Oncology

View Doximity Profile

Kathy D. Miller, MD

Hematology - Oncology

View Doximity Profile

Nabil Adra, MD

Hematology - Oncology

View Doximity Profile

Nasser H. Hanna, MD

Hematology - Oncology

View Doximity Profile